Click this tab to find out more about Investing in Missouri.

Medicinal Chemistry Group

Industry and academic units collaborate for advanced results

UMSL_LR.png
As federal research dollarrs become more limited, the university must find new ways to work with industry and grow ressarch through industrial funding. The work of the Medicinal Chemistry Group is a shining example of what can be accomplished when we seek out new partnerships and think beyond the traditional funding models. 

Since its move to the Innovative Technology Enterprises at the University of Missouri—St. Louis, the MCG has contracted with nine clients and its revenue is up 35 percent to the prior year with totals projected at $250,000.

Working with St. Louis University and One World Health (Gates Foundation) in the area of orphan and neglected diseases, the MCG is currently targeting the development of a treatment for childhood diarrhea, as well as the development of new anti-filarial agents to combat what is usually an infectious parasitic disease.

In addition to its contributions to drug discovery for orphan diseases, the MCG supports fledging startup companies in the region that do not have the necessary expertise and scientific capacity in house. These activities, often organized as fee-for-service contracts, provide low-cost solutions to scientific problems in a timely fashion.

The MCG is performing syntheses of new compounds for Confluence Discovery Technologies, Inc., a life sciences company that develops innovative treatments for animal and human diseases. The drugs are designed to target the large unmet medical needs associated with cancer and chronic inflammatory and autoimmune disease in both markets.

The group also provides syntheses work for BioMed Valley Discoveries, Inc., a research group funded by the Stowers Institute for Medical Research to address medical projects that are ‘too early, too challenging and too conventional for traditional biotech or pharmaceutical companies.’ These medicinal areas of concentration include cancer and inflammatory and infectious diseases.

For Midway Animal Health Inc., the MCG is performing preparative scale reverse phase purification to provide sufficient chemical quantities for a critical animal study that could result in a new veterinary medicine.

For more information on UMSL's Medicinal Chemistry Group, click here. 

 

Research Parks & Incubators

The University of Missouri System’s statewide network of research parks provides a thriving environment for discoveries to move from the laboratory to the marketplace. The atmosphere of innovation and collaboration attracts national and international tenants who create quality employment opportunities for Missouri citizens and millions of dollars of capital investment across the state.

Visit Site

Office of Intellectual Property Administration

The Office of Intellectual Property Administration (OIPA) supports the economic development mission by encouraging broad practical application of university research for the public benefit; assisting those associated with the technology transfer program with evaluating, protecting, licensing and commercializing university discoveries; and carrying out new economic development initiatives designed to create jobs in Missouri.

Visit Site

Funding Opportunities

The Office of Research and Economic Development is dedicated to commercializing university technologies - one of the biggest challenges to that mission is funding. To proactively combat the constant obstacle, the office has formulated different funding programs for faculty, students and innovations in all stages of the discovery process.

Visit Site

Office of Research & Economic Development

The Office of Research and Economic Development was established in 2005 to link research and commercialization from the four University of Missouri System campuses with emerging and existing firms across the state and around the world. Working closely with the chief research officers, chancellors and technology transfer offices from each campus, the office also serves as a conduit to local, state and federal agencies to ensure research results aid the growth of Missouri’s economy.

The Office is dedicated to advancing Missouri through innovation, investment and infrastructure.

Our enthusiasm for these three categories revolves around the development of intellectual property, funding programs and research parks and incubators. Providing support during critical stages in university inventions’ path to the marketplace stimulates Missouri’s economy, jobs and entrepreneurship.

Our vision is to enable and lead Missouri’s transformation toward a knowledge-based economy dependent upon innovation and entrepreneurship.

Contact Us

309 University Hall
Columbia MO, 65211
Phone: 573-882-6726
Email: email